Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,070 | -8,620 | -11,578 | -32,420 | -23,507 |
| Depreciation Amortization | 3,420 | 3,010 | 4,389 | 6,080 | 5,855 |
| Other Working Capital | 1,290 | -7,440 | -2,651 | -8,550 | -14,752 |
| Other Operating Activity | 4,530 | 2,850 | 3,762 | 14,610 | 14,165 |
| Operating Cash Flow | $-13,830 | $-10,200 | $-6,078 | $-20,280 | $-18,239 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,680 | -3,040 | -2,145 | -8,620 | -3,342 |
| Other Investing Activity | 23,140 | 5,480 | -36,754 | -35,680 | 10,732 |
| Investing Cash Flow | $17,460 | $2,440 | $-38,899 | $-44,300 | $7,390 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 300 | -1,400 | 39,424 | 66,320 | 19,939 |
| Financing Cash Flow | $300 | $-1,400 | $39,424 | $66,320 | $19,939 |
| Beginning Cash Position | 19,750 | 28,920 | 34,475 | 32,730 | 23,646 |
| End Cash Position | 23,690 | 19,750 | 28,921 | 34,470 | 32,736 |
| Net Cash Flow | $3,940 | $-9,160 | $-5,554 | $1,730 | $9,090 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,830 | -10,200 | -6,078 | -20,280 | -18,239 |
| Free Cash Flow | -13,830 | -10,200 | -6,078 | -20,280 | -18,239 |